Synageva, Trimeris deal

Synageva will merge with infectious disease company Trimeris in a stock deal. Synageva stockholders will own about 75%, while Trimeris shareholders will own the remaining 25% of the newco, to be called Synageva BioPharma Corp. MTS Securities advised Trimeris. ...